Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Hiroto Inaba, MD, PhD
St. Jude Children's Research Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Royal Children'S Hospital Melbourne
Parkville, Victoria, Australia
- Lucile Packard Children'S Hospital Stanford University
Palo Alto, California, United States
- Rady Children'S Hospital San Diego
San Diego, California, United States
- Children'S Hospital of Illinois at Osf-Saint Francis Medical Center (st. Jude Midwest Affiliate - Peoria)
Peoria, Illinois, United States
- Children'S Hospital of Michigan
Detroit, Michigan, United States
- St. Jude Affiliate Clinic - Novant Health Hemby Children'S Hospital
Charlotte, North Carolina, United States
- St. Jude Children'S Research Hospital
Memphis, Tennessee, United States
- Cook Children'S Medical Center
Fort Worth, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Mar 2017
- Primary completion
- 30 Sept 2026
- Completion
- 30 Sept 2028
- Last update posted
- 17 Jun 2026
- Registered enrollment
- 790
- Registry id
- NCT03117751
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.